Cardiac Rhythm Management Devices Market By Product (Pacemakers (Implantable Pacemakers, External Pacemakers), Defibrillators (Implantable Cardioverter Defibrillators (ICD) (Subcutaneous ICD (S-ICD), Transvenous ICD (T-ICD), External Defibrillators (ED) (Manual ED, Automated ED (AED), Wearable Cardioverter Defibrillator), Cardiac Resynchronization Therapy (CRT) (CRT Defibrillators (CRT-D), CRT Pacemakers (CRT-P); By End User (Hospitals and Clinics, Home Settings, Ambulatory Surgical Centers); By Region (U.S., Rest of North America, France, UK, Germany, Spain, Italy, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, GCC Countries, Southern Africa, Rest of MEA, Brazil, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2018 – 2026

Report ID :AMI-158 | Category : Medical Devices | Published Date : December, 2018 | Pages : 325 | Format :PDF

Industry Trends


Cardiac Rhythm Management (CRM) is the treatment of arrhythmias, which are heart rhythm disorders. Arrhythmias cause dizzy spells, blackouts, palpitations and sudden cardiac arrest in patients. Cardiac Rhythm Management usually involves implanting of electronic devices such as defibrillators and pacemakers. Cardiac rhythm management devices are used to determine heart health and enable the physicians to offer a faster diagnosis. Various CRM devices are also being utilized to monitor patient activity and intracardiac pressures. The extensive use of cardiac rhythm management devices (CRMDs) is substantially improving the long-term prognosis and survival rates.

A consistent rise in instances of cardiovascular diseases is being observed, due to various lifestyle and food related disorders, positively impacting the demand for cardiac rhythm management devices. High cost of these devices, as well as a shortage of skilled professionals with expertise in cardiac monitoring has limited its growth in several emerging markets. Evolutionary advancements of these devices are enhancing functionality by improving their battery life and reduction in the device size.

Cardiac Rhythm Management Devices Market is expected to grow with a CAGR of 6.5% during the forecast period of 2018 to 2026. The study analyzes the market in terms of revenue and sales volume across all the major markets.

Printed & Flexible Sensor MarketCardiac Rhythm Management Devices Market, by Product

Pacemakers (PM) are among the most commonly used cardiac rhythm management devices, which give electrical impulses to trigger the heartbeat when it is slow or stops altogether. An Implantable Cardioverter Defibrillator (ICD) automatically delivers a shock to restore the normal rhythm by detecting fast or chaotic beating of heart’s main pumping chamber, which often leads to sudden cardiac arrests. Most cardiac rhythm management devices also act as pacemakers and both these devices provide constant care to patients with irregular heart rhythms.

Cardiac Rhythm Management Devices Market, by Region

The significant presence of population requiring cardiac rhythm management therapy, due to the prevalence of serious risk factors such as diabetes, hypertension, obesity, and congestive heart failure across regions is influencing the demand of CRMDs in this market. Boston Scientific is a medical device manufacturer based in Marlborough, Massachusets, US, which markets a wide range of CRM devices. It is among the leading manufacturers of these products including RHYTHMIA HDx Mapping System that enables physicians to provide personalized care to patients suffering from arrhythmias. Biotronik is a company headquartered in Berlin, Germany and is gaining popularity for their CRT pacemaker with remote monitoring called Etrinsa 8 HF-T. The availability of such devices in the market catering to the specific requirements of cardiac patients is substantially improving cardiac care standards.

Competitive Landscape

The report provides both, qualitative and quantitative research of the cardiac rhythm management devices market, as well as provides worthy insights into the rational scenario and favored development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and detailed insights on the competitiveness of these players. The key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes their headquarter, competitors, product/service type, application and specification, pricing, and gross margin.

The Cardiac Rhythm Management Devices Market participants include Siemens AG, 3M Company(3M), Abiomed, Inc.(ABIOMED), Berlin Heart GmbH (Berlin Heart), Biotronik SE & Co. KG, Boston Scientific Corporation, Cardiac Science Corporation, General Electric Company (General Electric), Hill-Rom Services Inc., Jarvik Heart, Inc., Koninklijke Philips N.V., LivaNova PLC, Medtronic, NIHON KOHDEN CORPORATION, and ZOLL Medical Corporation amongst others.

Cardiac Rhythm Management Devices Market

Cardiac Rhythm Management Devices Market

Table of Contents

 


1.    Introduction

1.1. Market Scope

1.2. Market Segmentation

1.3. Methodology

1.4. Assumptions

2.    Cardiac Rhythm Management Devices Market Snapshot

3.    Executive Summary: Cardiac Rhythm Management Devices Market

4.    Qualitative Analysis: Cardiac Rhythm Management Devices Market

4.1. Introduction

4.1.1. Product Definition

4.1.2. Industry Development

4.2. Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Opportunities

4.3. Trends in Cardiac Rhythm Management Devices Market

4.4. PESTLE Analysis

4.5. Porter’s Five Forces Analysis

4.6. SWOT Analysis

5.    Global Cardiac Rhythm Management Devices Market Analysis and Forecasts, 2018 – 2026

5.1. Overview

5.1.1. Global Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts

5.2. Global Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Product

5.2.1. Pacemakers (Definition, Market Penetration, Market Revenue Expected to Increase by 2026, Compound Annual Growth Rate (CAGR) and information on Implantable Pacemakers, External Pacemakers)

5.2.1.1.    Implantable Pacemakers

5.2.1.2.    External Pacemakers

5.2.2. Defibrillators (Definition, Market Penetration, Market Revenue Expected to Increase by 2026, Compound Annual Growth Rate (CAGR) and information on Implantable Cardioverter Defibrillators (ICDs), External Defibrillator (ED))

5.2.2.1.    Implantable Cardioverter Defibrillators (ICDs)

5.2.2.2.     External Defibrillator (ED)

5.2.3. Implantable Cardioverter Defibrillators (ICDs) (Definition, Market Penetration, Market Revenue Expected to Increase by 2026, Compound Annual Growth Rate (CAGR) and information on Subcutaneous ICD (S-ICD), Transvenous ICD (T-ICD))

5.2.3.1.    Subcutaneous ICD (S-ICD)

5.2.3.2.    Transvenous ICD (T-ICD)

5.2.4. External Defibrillator (ED) (Definition, Market Penetration, Market Revenue Expected to Increase by 2026, Compound Annual Growth Rate (CAGR) and information on Manual ED, Automated ED (AED), Wearable Cardioverter Defibrillator)

5.2.4.1.    Manual ED

5.2.4.2.    Automated ED (AED)

5.2.4.3.    Wearable Cardioverter Defibrillator

5.2.5. Cardiac Resynchronization Therapy (CRT) (Definition, Market Penetration, Market Revenue Expected to Increase by 2026, Compound Annual Growth Rate (CAGR) and information on CRT Defibrillators (CRT-D), CRT Pacemakers (CRT-P))

5.2.5.1.    CRT Defibrillators (CRT-D)

5.2.5.2.    CRT Pacemakers (CRT-P)

5.3. Key Segment for Channeling Investments

5.3.1. By Product

6.    Global Cardiac Rhythm Management Devices Market Analysis and Forecasts, 2018 – 2026

6.1. Overview

6.2. Global Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By End User

6.2.1. Hospitals and Clinics

6.2.1.1.    Definition

6.2.1.2.    Market Penetration

6.2.1.3.    Market Revenue Expected to Increase by 2026

6.2.1.4.    Compound Annual Growth Rate (CAGR)

6.2.2. Home Settings

6.2.2.1.    Definition

6.2.2.2.    Market Penetration

6.2.2.3.    Market Revenue Expected to Increase by 2026

6.2.2.4.    Compound Annual Growth Rate (CAGR)

6.2.3. Ambulatory Service Centers

6.2.3.1.    Definition

6.2.3.2.    Market Penetration

6.2.3.3.    Market Revenue Expected to Increase by 2026

6.2.3.4.    Compound Annual Growth Rate (CAGR)

6.3. Key Segment for Channeling Investments

6.3.1. By End User

7.    North America Cardiac Rhythm Management Devices Market Analysis and Forecasts, 2018 – 2026

7.1. Overview

7.1.1. North America Cardiac Rhythm Management Devices Market Revenue (US$ Mn)

7.2. North America Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Product

7.2.1. Pacemakers

7.2.1.1.    Implantable Pacemakers

7.2.1.2.    External Pacemakers

7.2.2. Defibrillators

7.2.2.1.    Implantable Cardioverter Defibrillators (ICDs)

7.2.2.1.1.    Subcutaneous ICD (S-ICD)

7.2.2.1.2.    Transvenous ICD (T-ICD)

7.2.2.2.    External Defibrillator (ED)

7.2.2.2.1.    Manual ED

7.2.2.2.2.    Automated ED (AED)

7.2.2.2.3.    Wearable Cardioverter Defibrillator

7.2.3. Cardiac Resynchronization Therapy (CRT)

7.2.3.1.    CRT Defibrillators (CRT-D)

7.2.3.2.    CRT Pacemakers (CRT-P)

7.3. North America Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By End User

7.3.1. Hospitals and Clinics

7.3.2. Home Settings

7.3.3. Ambulatory Service Centers

7.4. North America Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Country

7.4.1. U.S.

7.4.1.1.    U.S. Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Product

7.4.1.1.1.    Pacemakers

7.4.1.1.1.1. Implantable Pacemakers

7.4.1.1.1.2. External Pacemakers

7.4.1.1.2.    Defibrillators

7.4.1.1.3.    Implantable Cardioverter Defibrillators (ICDs)

7.4.1.1.3.1. Subcutaneous ICD (S-ICD)

7.4.1.1.3.2. Transvenous ICD (T-ICD)

7.4.1.1.4.    External Defibrillator (ED)

7.4.1.1.4.1. Manual ED

7.4.1.1.4.2. Automated ED (AED)

7.4.1.1.4.3. Wearable Cardioverter Defibrillator

7.4.1.1.5.    Cardiac Resynchronization Therapy (CRT)

7.4.1.1.5.1. CRT Defibrillators (CRT-D)

7.4.1.1.5.2. CRT Pacemakers (CRT-P)

7.4.1.2.    U.S. Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By End User

7.4.1.2.1.    Hospitals and Clinics

7.4.1.2.2.    Home Settings

7.4.1.2.3.    Ambulatory Service Centers

7.4.2. Rest of North America

7.4.2.1.    Rest of North America Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Product

7.4.2.1.1.    Pacemakers

7.4.2.1.1.1. Implantable Pacemakers

7.4.2.1.1.2. External Pacemakers

7.4.2.1.2.    Defibrillators

7.4.2.1.2.1. Implantable Cardioverter Defibrillators (ICDs)

7.4.2.1.2.1.1.       Subcutaneous ICD (S-ICD)

7.4.2.1.2.1.2.       Transvenous ICD (T-ICD)

7.4.2.1.2.2. External Defibrillator (ED)

7.4.2.1.2.2.1.       Manual ED

7.4.2.1.2.2.2.       Automated ED (AED)

7.4.2.1.2.2.3.       Wearable Cardioverter Defibrillator

7.4.2.1.3.    Cardiac Resynchronization Therapy (CRT)

7.4.2.1.3.1. CRT Defibrillators (CRT-D)

7.4.2.1.3.2. CRT Pacemakers (CRT-P)

7.4.2.2.    Rest of North America Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By End User

7.4.2.2.1.    Hospitals and Clinics

7.4.2.2.2.    Home Settings

7.4.2.2.3.    Ambulatory Service Centers

7.5. Key Segment for Channeling Investments

7.5.1. By Country

7.5.2. By Product

7.5.3. By End User

8.    Europe Cardiac Rhythm Management Devices Market Analysis and Forecasts, 2018 – 2026

8.1. Overview

8.1.1. Europe Cardiac Rhythm Management Devices Market Revenue (US$ Mn)

8.2. Europe Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Product

8.2.1. Pacemakers

8.2.1.1.    Implantable Pacemakers

8.2.1.2.    External Pacemakers

8.2.2. Defibrillators

8.2.2.1.    Implantable Cardioverter Defibrillators (ICDs)

8.2.2.1.1.    Subcutaneous ICD (S-ICD)

8.2.2.1.2.    Transvenous ICD (T-ICD)

8.2.2.2.    External Defibrillator (ED)

8.2.2.2.1.    Manual ED

8.2.2.2.2.    Automated ED (AED)

8.2.2.2.3.    Wearable Cardioverter Defibrillator

8.2.3. Cardiac Resynchronization Therapy (CRT)

8.2.3.1.    CRT Defibrillators (CRT-D)

8.2.3.2.    CRT Pacemakers (CRT-P)

8.3. Europe Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By End User

8.3.1. Hospitals and Clinics

8.3.2. Home Settings

8.3.3. Ambulatory Service Centers

8.4. Europe Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Country

8.4.1. France

8.4.1.1.    France Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Product

8.4.1.1.1.    Pacemakers

8.4.1.1.1.1. Implantable Pacemakers

8.4.1.1.1.2. External Pacemakers

8.4.1.1.2.    Defibrillators

8.4.1.1.2.1. Implantable Cardioverter Defibrillators (ICDs)

8.4.1.1.2.1.1.       Subcutaneous ICD (S-ICD)

8.4.1.1.2.1.2.       Transvenous ICD (T-ICD)

8.4.1.1.2.2. External Defibrillator (ED)

8.4.1.1.2.2.1.       Manual ED

8.4.1.1.2.2.2.       Automated ED (AED)

8.4.1.1.2.2.3.       Wearable Cardioverter Defibrillator

8.4.1.1.3.    Cardiac Resynchronization Therapy (CRT)

8.4.1.1.3.1. CRT Defibrillators (CRT-D)

8.4.1.1.3.2. CRT Pacemakers (CRT-P)

8.4.1.2.    France Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By End User

8.4.1.2.1.    Hospitals and Clinics

8.4.1.2.2.    Home Settings

8.4.1.2.3.    Ambulatory Service Centers

8.4.2. The UK

8.4.2.1.    The UK Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Product

8.4.2.1.1.    Pacemakers

8.4.2.1.1.1. Implantable Pacemakers

8.4.2.1.1.2. External Pacemakers

8.4.2.1.2.    Defibrillators

8.4.2.1.2.1. Implantable Cardioverter Defibrillators (ICDs)

8.4.2.1.2.1.1.       Subcutaneous ICD (S-ICD)

8.4.2.1.2.1.2.       Transvenous ICD (T-ICD)

8.4.2.1.2.2. External Defibrillator (ED)

8.4.2.1.2.2.1.       Manual ED

8.4.2.1.2.2.2.       Automated ED (AED)

8.4.2.1.2.2.3.       Wearable Cardioverter Defibrillator

8.4.2.1.3.    Cardiac Resynchronization Therapy (CRT)

8.4.2.1.3.1. CRT Defibrillators (CRT-D)

8.4.2.1.3.2. CRT Pacemakers (CRT-P)

8.4.2.2.    The UK Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By End User

8.4.2.2.1.    Hospitals and Clinics

8.4.2.2.2.    Home Settings

8.4.2.2.3.    Ambulatory Service Centers

8.4.3. Spain

8.4.3.1.    Spain Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Product

8.4.3.1.1.    Pacemakers

8.4.3.1.1.1. Implantable Pacemakers

8.4.3.1.1.2. External Pacemakers

8.4.3.1.2.    Defibrillators

8.4.3.1.2.1. Implantable Cardioverter Defibrillators (ICDs)

8.4.3.1.2.1.1.       Subcutaneous ICD (S-ICD)

8.4.3.1.2.1.2.       Transvenous ICD (T-ICD)

8.4.3.1.2.2. External Defibrillator (ED)

8.4.3.1.2.2.1.       Manual ED

8.4.3.1.2.2.2.       Automated ED (AED)

8.4.3.1.2.2.3.       Wearable Cardioverter Defibrillator

8.4.3.1.3.    Cardiac Resynchronization Therapy (CRT)

8.4.3.1.3.1. CRT Defibrillators (CRT-D)

8.4.3.1.3.2. CRT Pacemakers (CRT-P)

8.4.3.2.    Spain Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By End User

8.4.3.2.1.    Hospitals and Clinics

8.4.3.2.2.    Home Settings

8.4.3.2.3.    Ambulatory Service Centers

8.4.4. Germany

8.4.4.1.    Germany Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Product

8.4.4.1.1.    Pacemakers

8.4.4.1.1.1. Implantable Pacemakers

8.4.4.1.1.2. External Pacemakers

8.4.4.1.2.    Defibrillators

8.4.4.1.2.1. Implantable Cardioverter Defibrillators (ICDs)

8.4.4.1.2.1.1.       Subcutaneous ICD (S-ICD)

8.4.4.1.2.1.2.       Transvenous ICD (T-ICD)

8.4.4.1.2.2. External Defibrillator (ED)

8.4.4.1.2.2.1.       Manual ED

8.4.4.1.2.2.2.       Automated ED (AED)

8.4.4.1.2.2.3.       Wearable Cardioverter Defibrillator

8.4.4.1.3.    Cardiac Resynchronization Therapy (CRT)

8.4.4.1.3.1. CRT Defibrillators (CRT-D)

8.4.4.1.3.2. CRT Pacemakers (CRT-P)

8.4.4.2.    Germany Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By End User

8.4.4.2.1.    Hospitals and Clinics

8.4.4.2.2.    Home Settings

8.4.4.2.3.    Ambulatory Service Centers

8.4.5. Italy

8.4.5.1.    Italy Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Product

8.4.5.1.1.    Pacemakers

8.4.5.1.1.1. Implantable Pacemakers

8.4.5.1.1.2. External Pacemakers

8.4.5.1.2.    Defibrillators

8.4.5.1.2.1. Implantable Cardioverter Defibrillators (ICDs)

8.4.5.1.2.1.1.       Subcutaneous ICD (S-ICD)

8.4.5.1.2.1.2.       Transvenous ICD (T-ICD)

8.4.5.1.2.2. External Defibrillator (ED)

8.4.5.1.2.2.1.       Manual ED

8.4.5.1.2.2.2.       Automated ED (AED)

8.4.5.1.2.2.3.       Wearable Cardioverter Defibrillator

8.4.5.1.3.    Cardiac Resynchronization Therapy (CRT)

8.4.5.1.3.1. CRT Defibrillators (CRT-D)

8.4.5.1.3.2. CRT Pacemakers (CRT-P)

8.4.5.2.    Italy Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By End User

8.4.5.2.1.    Hospitals and Clinics

8.4.5.2.2.    Home Settings

8.4.5.2.3.    Ambulatory Service Centers

8.4.6. Rest of Europe

8.4.6.1.    Rest of Europe Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Product

8.4.6.1.1.    Pacemakers

8.4.6.1.1.1. Implantable Pacemakers

8.4.6.1.1.2. External Pacemakers

8.4.6.1.2.    Defibrillators

8.4.6.1.2.1. Implantable Cardioverter Defibrillators (ICDs)

8.4.6.1.2.1.1.       Subcutaneous ICD (S-ICD)

8.4.6.1.2.1.2.       Transvenous ICD (T-ICD)

8.4.6.1.2.2. External Defibrillator (ED)

8.4.6.1.2.2.1.       Manual ED

8.4.6.1.2.2.2.       Automated ED (AED)

8.4.6.1.2.2.3.       Wearable Cardioverter Defibrillator

8.4.6.1.3.    Cardiac Resynchronization Therapy (CRT)

8.4.6.1.3.1. CRT Defibrillators (CRT-D)

8.4.6.1.3.2. CRT Pacemakers (CRT-P)

8.4.6.2.    Rest of Europe Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By End User

8.4.6.2.1.    Hospitals and Clinics

8.4.6.2.2.    Home Settings

8.4.6.2.3.    Ambulatory Service Centers

8.5. Key Segment for Channeling Investments

8.5.1. By Country

8.5.2. By Product

8.5.3. By End User

9.    Asia Pacific Cardiac Rhythm Management Devices Market Analysis and Forecasts, 2018 – 2026

9.1. Overview

9.1.1. Asia Pacific Cardiac Rhythm Management Devices Market Revenue (US$ Mn)

9.2. Asia Pacific Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Product

9.2.1. Pacemakers

9.2.1.1.    Implantable Pacemakers

9.2.1.2.    External Pacemakers

9.2.2. Defibrillators

9.2.2.1.    Implantable Cardioverter Defibrillators (ICDs)

9.2.2.1.1.    Subcutaneous ICD (S-ICD)

9.2.2.1.2.    Transvenous ICD (T-ICD)

9.2.2.2.    External Defibrillator (ED)

9.2.2.2.1.    Manual ED

9.2.2.2.2.    Automated ED (AED)

9.2.2.2.3.    Wearable Cardioverter Defibrillator

9.2.3. Cardiac Resynchronization Therapy (CRT)

9.2.3.1.    CRT Defibrillators (CRT-D)

9.2.3.2.    CRT Pacemakers (CRT-P)

9.3. Asia Pacific Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By End User

9.3.1. Hospitals and Clinics

9.3.2. Home Settings

9.3.3. Ambulatory Service Centers

9.4. Asia Pacific Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Country

9.4.1. China

9.4.1.1.    China Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Product

9.4.1.1.1.    Pacemakers

9.4.1.1.1.1. Implantable Pacemakers

9.4.1.1.1.2. External Pacemakers

9.4.1.1.2.    Defibrillators

9.4.1.1.2.1. Implantable Cardioverter Defibrillators (ICDs)

9.4.1.1.2.1.1.       Subcutaneous ICD (S-ICD)

9.4.1.1.2.1.2.       Transvenous ICD (T-ICD)

9.4.1.1.2.2. External Defibrillator (ED)

9.4.1.1.2.2.1.       Manual ED

9.4.1.1.2.2.2.       Automated ED (AED)

9.4.1.1.2.2.3.       Wearable Cardioverter Defibrillator

9.4.1.1.3.    Cardiac Resynchronization Therapy (CRT)

9.4.1.1.3.1. CRT Defibrillators (CRT-D)

9.4.1.1.3.2. CRT Pacemakers (CRT-P)

9.4.1.2.    China Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By End User

9.4.1.2.1.    Hospitals and Clinics

9.4.1.2.2.    Home Settings

9.4.1.2.3.    Ambulatory Service Centers

9.4.2. Japan

9.4.2.1.    Japan Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Product

9.4.2.1.1.    Pacemakers

9.4.2.1.1.1. Implantable Pacemakers

9.4.2.1.1.2. External Pacemakers

9.4.2.1.2.    Defibrillators

9.4.2.1.2.1. Implantable Cardioverter Defibrillators (ICDs)

9.4.2.1.2.1.1.       Subcutaneous ICD (S-ICD)

9.4.2.1.2.1.2.       Transvenous ICD (T-ICD)

9.4.2.1.2.2. External Defibrillator (ED)

9.4.2.1.2.2.1.       Manual ED

9.4.2.1.2.2.2.       Automated ED (AED)

9.4.2.1.2.2.3.       Wearable Cardioverter Defibrillator

9.4.2.1.3.    Cardiac Resynchronization Therapy (CRT)

9.4.2.1.3.1. CRT Defibrillators (CRT-D)

9.4.2.1.3.2. CRT Pacemakers (CRT-P)

9.4.2.2.    Japan Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By End User

9.4.2.2.1.    Hospitals and Clinics

9.4.2.2.2.    Home Settings

9.4.2.2.3.    Ambulatory Service Centers

9.4.3. India

9.4.3.1.    India Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Product

9.4.3.1.1.    Pacemakers

9.4.3.1.1.1. Implantable Pacemakers

9.4.3.1.1.2. External Pacemakers

9.4.3.1.2.    Defibrillators

9.4.3.1.2.1. Implantable Cardioverter Defibrillators (ICDs)

9.4.3.1.2.1.1.       Subcutaneous ICD (S-ICD)

9.4.3.1.2.1.2.       Transvenous ICD (T-ICD)

9.4.3.1.2.2. External Defibrillator (ED)

9.4.3.1.2.2.1.       Manual ED

9.4.3.1.2.2.2.       Automated ED (AED)

9.4.3.1.2.2.3.       Wearable Cardioverter Defibrillator

9.4.3.1.3.    Cardiac Resynchronization Therapy (CRT)

9.4.3.1.3.1. CRT Defibrillators (CRT-D)

9.4.3.1.3.2. CRT Pacemakers (CRT-P)

9.4.3.2.    India Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By End User

9.4.3.2.1.    Hospitals and Clinics

9.4.3.2.2.    Home Settings

9.4.3.2.3.    Ambulatory Service Centers

9.4.4. Southeast Asia

9.4.4.1.    Southeast Asia Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Product

9.4.4.1.1.    Pacemakers

9.4.4.1.1.1. Implantable Pacemakers

9.4.4.1.1.2. External Pacemakers

9.4.4.1.2.    Defibrillators

9.4.4.1.2.1. Implantable Cardioverter Defibrillators (ICDs)

9.4.4.1.2.1.1.       Subcutaneous ICD (S-ICD)

9.4.4.1.2.1.2.       Transvenous ICD (T-ICD)

9.4.4.1.2.2. External Defibrillator (ED)

9.4.4.1.2.2.1.       Manual ED

9.4.4.1.2.2.2.       Automated ED (AED)

9.4.4.1.2.2.3.       Wearable Cardioverter Defibrillator

9.4.4.1.3.    Cardiac Resynchronization Therapy (CRT)

9.4.4.1.3.1. CRT Defibrillators (CRT-D)

9.4.4.1.3.2. CRT Pacemakers (CRT-P)

9.4.4.2.    Southeast Asia Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By End User

9.4.4.2.1.    Hospitals and Clinics

9.4.4.2.2.    Home Settings

9.4.4.2.3.    Ambulatory Service Centers

9.4.5. Rest of Asia Pacific

9.4.5.1.    Rest of Asia Pacific Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Product

9.4.5.1.1.    Pacemakers

9.4.5.1.1.1. Implantable Pacemakers

9.4.5.1.1.2. External Pacemakers

9.4.5.1.2.    Defibrillators

9.4.5.1.2.1. Implantable Cardioverter Defibrillators (ICDs)

9.4.5.1.2.1.1.       Subcutaneous ICD (S-ICD)

9.4.5.1.2.1.2.       Transvenous ICD (T-ICD)

9.4.5.1.2.2. External Defibrillator (ED)

9.4.5.1.2.2.1.       Manual ED

9.4.5.1.2.2.2.       Automated ED (AED)

9.4.5.1.2.2.3.       Wearable Cardioverter Defibrillator

9.4.5.1.3.    Cardiac Resynchronization Therapy (CRT)

9.4.5.1.3.1. CRT Defibrillators (CRT-D)

9.4.5.1.3.2. CRT Pacemakers (CRT-P)

9.4.5.2.    Rest of Asia Pacific Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By End User

9.4.5.2.1.    Hospitals and Clinics

9.4.5.2.2.    Home Settings

9.4.5.2.3.    Ambulatory Service Centers

9.5. Key Segment for Channeling Investments

9.5.1. By Country

9.5.2. By Product

9.5.3. By End User

10. Middle East and Africa Cardiac Rhythm Management Devices Market Analysis and Forecasts, 2018 – 2026

10.1. Overview

10.1.1. Middle East and Africa Cardiac Rhythm Management Devices Market Revenue (US$ Mn)

10.2. Middle East and Africa Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Product

10.2.1. Pacemakers

10.2.1.1.  Implantable Pacemakers

10.2.1.2.  External Pacemakers

10.2.2. Defibrillators

10.2.2.1.  Implantable Cardioverter Defibrillators (ICDs)

10.2.2.1.1.  Subcutaneous ICD (S-ICD)

10.2.2.1.2.  Transvenous ICD (T-ICD)

10.2.2.2.  External Defibrillator (ED)

10.2.2.2.1.  Manual ED

10.2.2.2.2.  Automated ED (AED)

10.2.2.2.3.  Wearable Cardioverter Defibrillator

10.2.3. Cardiac Resynchronization Therapy (CRT)

10.2.3.1.  CRT Defibrillators (CRT-D)

10.2.3.2.  CRT Pacemakers (CRT-P)

10.3. Middle East and Africa Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By End User

10.3.1. Hospitals and Clinics

10.3.2. Home Settings

10.3.3. Ambulatory Service Centers

10.4. Middle East and Africa Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Country

10.4.1. GCC Countries

10.4.1.1.  GCC Countries Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Product

10.4.1.1.1.  Pacemakers

10.4.1.1.1.1. Implantable Pacemakers

10.4.1.1.1.2. External Pacemakers

10.4.1.1.2.  Defibrillators

10.4.1.1.2.1. Implantable Cardioverter Defibrillators (ICDs)

10.4.1.1.2.1.1.    Subcutaneous ICD (S-ICD)

10.4.1.1.2.1.2.    Transvenous ICD (T-ICD)

10.4.1.1.2.2. External Defibrillator (ED)

10.4.1.1.2.2.1.    Manual ED

10.4.1.1.2.2.2.    Automated ED (AED)

10.4.1.1.2.2.3.    Wearable Cardioverter Defibrillator

10.4.1.1.3.  Cardiac Resynchronization Therapy (CRT)

10.4.1.1.3.1. CRT Defibrillators (CRT-D)

10.4.1.1.3.2. CRT Pacemakers (CRT-P)

10.4.1.2.  GCC Countries Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By End User

10.4.1.2.1.  Hospitals and Clinics

10.4.1.2.2.  Home Settings

10.4.1.2.3.  Ambulatory Service Centers

10.4.2. Southern Africa

10.4.2.1.  Southern Africa Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Product

10.4.2.1.1.  Pacemakers

10.4.2.1.1.1. Implantable Pacemakers

10.4.2.1.1.2. External Pacemakers

10.4.2.1.2.  Defibrillators

10.4.2.1.2.1. Implantable Cardioverter Defibrillators (ICDs)

10.4.2.1.2.1.1.    Subcutaneous ICD (S-ICD)

10.4.2.1.2.1.2.    Transvenous ICD (T-ICD)

10.4.2.1.2.2. External Defibrillator (ED)

10.4.2.1.2.2.1.    Manual ED

10.4.2.1.2.2.2.    Automated ED (AED)

10.4.2.1.2.2.3.    Wearable Cardioverter Defibrillator

10.4.2.1.3.  Cardiac Resynchronization Therapy (CRT)

10.4.2.1.3.1. CRT Defibrillators (CRT-D)

10.4.2.1.3.2. CRT Pacemakers (CRT-P)

10.4.2.2.  Southern Africa Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By End User

10.4.2.2.1.  Hospitals and Clinics

10.4.2.2.2.  Home Settings

10.4.2.2.3.  Ambulatory Service Centers

10.4.3. Rest of MEA

10.4.3.1.  Rest of MEA Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Product

10.4.3.1.1.  Pacemakers

10.4.3.1.1.1. Implantable Pacemakers

10.4.3.1.1.2. External Pacemakers

10.4.3.1.2.  Defibrillators

10.4.3.1.2.1. Implantable Cardioverter Defibrillators (ICDs)

10.4.3.1.2.1.1.    Subcutaneous ICD (S-ICD)

10.4.3.1.2.1.2.    Transvenous ICD (T-ICD)

10.4.3.1.2.2. External Defibrillator (ED)

10.4.3.1.2.2.1.    Manual ED

10.4.3.1.2.2.2.    Automated ED (AED)

10.4.3.1.2.2.3.    Wearable Cardioverter Defibrillator

10.4.3.1.3.  Cardiac Resynchronization Therapy (CRT)

10.4.3.1.3.1. CRT Defibrillators (CRT-D)

10.4.3.1.3.2. CRT Pacemakers (CRT-P)

10.4.3.2.  Rest of MEA Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By End User

10.4.3.2.1.  Hospitals and Clinics

10.4.3.2.2.  Home Settings

10.4.3.2.3.  Ambulatory Service Centers

10.5. Key Segment for Channeling Investments

10.5.1. By Country

10.5.2. By Product

10.5.3. By End User

11. Latin America Cardiac Rhythm Management Devices Market Analysis and Forecasts, 2018 – 2026

11.1. Overview

11.1.1. Latin America Cardiac Rhythm Management Devices Market Revenue (US$ Mn)

11.2. Latin America Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Product

11.2.1. Pacemakers

11.2.1.1.  Implantable Pacemakers

11.2.1.2.  External Pacemakers

11.2.2. Defibrillators

11.2.2.1.  Implantable Cardioverter Defibrillators (ICDs)

11.2.2.1.1.  Subcutaneous ICD (S-ICD)

11.2.2.1.2.  Transvenous ICD (T-ICD)

11.2.2.2.  External Defibrillator (ED)

11.2.2.2.1.  Manual ED

11.2.2.2.2.  Automated ED (AED)

11.2.2.2.3.  Wearable Cardioverter Defibrillator

11.2.3. Cardiac Resynchronization Therapy (CRT)

11.2.3.1.  CRT Defibrillators (CRT-D)

11.2.3.2.  CRT Pacemakers (CRT-P)

11.3. Latin America Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By End User

11.3.1. Hospitals and Clinics

11.3.2. Home Settings

11.3.3. Ambulatory Service Centers

11.4. Latin America Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Country

11.4.1. Brazil

11.4.1.1.  Brazil Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Product

11.4.1.1.1.  Pacemakers

11.4.1.1.1.1. Implantable Pacemakers

11.4.1.1.1.2. External Pacemakers

11.4.1.1.2.  Defibrillators

11.4.1.1.2.1. Implantable Cardioverter Defibrillators (ICDs)

11.4.1.1.2.1.1.    Subcutaneous ICD (S-ICD)

11.4.1.1.2.1.2.    Transvenous ICD (T-ICD)

11.4.1.1.2.2. External Defibrillator (ED)

11.4.1.1.2.2.1.    Manual ED

11.4.1.1.2.2.2.    Automated ED (AED)

11.4.1.1.2.2.3.    Wearable Cardioverter Defibrillator

11.4.1.1.3.  Cardiac Resynchronization Therapy (CRT)

11.4.1.1.3.1. CRT Defibrillators (CRT-D)

11.4.1.1.3.2. CRT Pacemakers (CRT-P)

11.4.1.2.  Brazil Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By End User

11.4.1.2.1.  Hospitals and Clinics

11.4.1.2.2.  Home Settings

11.4.1.2.3.  Ambulatory Service Centers

11.4.2. Rest of Latin America

11.4.2.1.  Rest of Latin America Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By Product

11.4.2.1.1.  Pacemakers

11.4.2.1.1.1. Implantable Pacemakers

11.4.2.1.1.2. External Pacemakers

11.4.2.1.2.  Defibrillators

11.4.2.1.2.1. Implantable Cardioverter Defibrillators (ICDs)

11.4.2.1.2.1.1.    Subcutaneous ICD (S-ICD)

11.4.2.1.2.1.2.    Transvenous ICD (T-ICD)

11.4.2.1.2.2. External Defibrillator (ED)

11.4.2.1.2.2.1.    Manual ED

11.4.2.1.2.2.2.    Automated ED (AED)

11.4.2.1.2.2.3.    Wearable Cardioverter Defibrillator

11.4.2.1.3.  Cardiac Resynchronization Therapy (CRT)

11.4.2.1.3.1. CRT Defibrillators (CRT-D)

11.4.2.1.3.2. CRT Pacemakers (CRT-P)

11.4.2.2.  Rest of Latin America Cardiac Rhythm Management Devices Market Revenue (US$ Mn) and Forecasts, By End User

11.4.2.2.1.  Hospitals and Clinics

11.4.2.2.2.  Home Settings

11.4.2.2.3.  Ambulatory Service Centers

11.5. Key Segment for Channeling Investments

11.5.1. By Country

11.5.2. By Product

11.5.3. By End User

12. Competitive Benchmarking

12.1. Player Positioning Analysis

12.2. Global Presence and Growth Strategies

13. Player Profiles

13.1. 3M Company (3M)

13.1.1. Company Details

13.1.2. Company Overview

13.1.3. Product Offerings

13.1.4. Key Developments

13.1.5. Financial Analysis

13.1.6. SWOT Analysis

13.1.7. Business Strategies

13.2. Abiomed, Inc. (ABIOMED)

13.2.1. Company Details

13.2.2. Company Overview

13.2.3. Product Offerings

13.2.4. Key Developments

13.2.5. Financial Analysis

13.2.6. SWOT Analysis

13.2.7. Business Strategies

13.3. Berlin Heart GmbH (Berlin Heart)

13.3.1. Company Details

13.3.2. Company Overview

13.3.3. Product Offerings

13.3.4. Key Developments

13.3.5. Financial Analysis

13.3.6. SWOT Analysis

13.3.7. Business Strategies

13.4. Biotronik SE and Co. KG

13.4.1. Company Details

13.4.2. Company Overview

13.4.3. Product Offerings

13.4.4. Key Developments

13.4.5. Financial Analysis

13.4.6. SWOT Analysis

13.4.7. Business Strategies

13.5. Boston Scientific Corporation

13.5.1. Company Details

13.5.2. Company Overview

13.5.3. Product Offerings

13.5.4. Key Developments

13.5.5. Financial Analysis

13.5.6. SWOT Analysis

13.5.7. Business Strategies

13.6. Cardiac Science Corporation

13.6.1. Company Details

13.6.2. Company Overview

13.6.3. Product Offerings

13.6.4. Key Developments

13.6.5. Financial Analysis

13.6.6. SWOT Analysis

13.6.7. Business Strategies

13.7. General Electric Company (General Electric)

13.7.1. Company Details

13.7.2. Company Overview

13.7.3. Product Offerings

13.7.4. Key Developments

13.7.5. Financial Analysis

13.7.6. SWOT Analysis

13.7.7. Business Strategies

13.8. Hill-Rom Services Inc.

13.8.1. Company Details

13.8.2. Company Overview

13.8.3. Product Offerings

13.8.4. Key Developments

13.8.5. Financial Analysis

13.8.6. SWOT Analysis

13.8.7. Business Strategies

13.9. Jarvik Heart, Inc.

13.9.1. Company Details

13.9.2. Company Overview

13.9.3. Product Offerings

13.9.4. Key Developments

13.9.5. Financial Analysis

13.9.6. SWOT Analysis

13.9.7. Business Strategies

13.10. Koninklijke Philips N.V.

13.10.1. Company Details

13.10.2. Company Overview

13.10.3. Product Offerings

13.10.4. Key Developments

13.10.5. Financial Analysis

13.10.6. SWOT Analysis

13.10.7. Business Strategies

13.11. LivaNova PLC

13.11.1. Company Details

13.11.2. Company Overview

13.11.3. Product Offerings

13.11.4. Key Developments

13.11.5. Financial Analysis

13.11.6. SWOT Analysis

13.11.7. Business Strategies

13.12. Medtronic

13.12.1. Company Details

13.12.2. Company Overview

13.12.3. Product Offerings

13.12.4. Key Developments

13.12.5. Financial Analysis

13.12.6. SWOT Analysis

13.12.7. Business Strategies

13.13. NIHON KOHDEN CORPORATION

13.13.1. Company Details

13.13.2. Company Overview

13.13.3. Product Offerings

13.13.4. Key Developments

13.13.5. Financial Analysis

13.13.6. SWOT Analysis

13.13.7. Business Strategies

13.14. Siemens AG

13.14.1. Company Details

13.14.2. Company Overview

13.14.3. Product Offerings

13.14.4. Key Developments

13.14.5. Financial Analysis

13.14.6. SWOT Analysis

13.14.7. Business Strategies

13.15. ZOLL Medical Corporation

13.15.1. Company Details

13.15.2. Company Overview

13.15.3. Product Offerings

13.15.4. Key Developments

13.15.5. Financial Analysis

13.15.6. SWOT Analysis

13.15.7. Business Strategies

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews  are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.  

Prominent participants in our primary research process include:

  • Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
  • Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

  • Reuters
  • Factiva
  • Bloomberg
  • One Source
  • Hoovers

Research Methodology

Methodology

Key Inclusions

Methodology

Request A Sample

Ask for Discount

Enquiry Before Buying

Request For Customization

Purchase Options

Buy Now

Reach to us

Call us on

+91-74002-42424

Drop us an email at

sales@absolutemarketsinsights.com